Network-based screening identifies sitagliptin as an antitumor drug targeting dendritic cells
Background
Dendritic cell (DC)-mediated antigen presentation is essential for the priming and activation of tumor-specific T cells. However, few drugs that specifically manipulate DC functions are available. The identification of drugs targeting DC ho…